Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 10.97 is 29% above its 5-year average of 8.52, near the low end of its 5-year range (2.61–41.70).
As of the fiscal period ended Tuesday, June 30, 2026. 4.04% above its 12-month average of 10.54.
Reported quarterly current ratio; no daily interpolation. Q1 FY2027 (2026-06-30): 10.97.
CURRENT RATIO
10.97
CURRENT RATIO AVG TTM
10.54
CURRENT RATIO AVG 3Y
9.63
CURRENT RATIO AVG 5Y
8.52
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.04%
CURRENT VS 3Y AVG
+13.85%
CURRENT VS 5Y AVG
+28.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.73
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+194.46%
vs the sector median at left
Market Cap
$667.05M
Current Ratio
8.03
TTM Avg
12.16
3Y Avg
13.50
5Y Avg
14.42
Market Cap
$664.16M
Current Ratio
14.16
TTM Avg
12.98
3Y Avg
15.39
5Y Avg
17.04
Market Cap
$657.51M
Current Ratio
1.36
TTM Avg
1.59
3Y Avg
1.59
5Y Avg
1.59
Market Cap
$682.26M
Current Ratio
13.82
TTM Avg
5.67
3Y Avg
7.51
5Y Avg
7.66
Market Cap
$697.52M
Current Ratio
8.86
TTM Avg
10.22
3Y Avg
11.35
5Y Avg
25.38
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Helus Pharma Inc. (HELP) | $671.07M | 10.97 | 10.54 | 9.63 | 8.52 |
| MiMedx Group, Inc. (MDXG)vs › | $668.98M | 5.33 | 4.27 | 3.79 | 3.57 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $667.05M | 8.03 | 12.16 | 13.50 | 14.42 |
| Annexon, Inc. (ANNX)vs › | $664.38M | 5.53 | 8.02 | 10.47 | 14.43 |
| ArriVent BioPharma, Inc. (AVBP)vs › | $664.16M | 14.16 | 12.98 | 15.39 | 17.04 |
| Starling Oncology, Inc. (STLN)vs › | $657.51M | 1.36 | 1.59 | 1.59 | 1.59 |
| Verastem, Inc. (VSTM)vs › | $679.70M | 2.25 | 3.08 | 3.98 | 5.01 |
| Solid Biosciences Inc. (SLDB)vs › | $682.26M | 13.82 | 5.67 | 7.51 | 7.66 |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $697.52M | 8.86 | 10.22 | 11.35 | 25.38 |
| OmniAb, Inc. (OABI)vs › | $639.31M | 4.80 | 4.27 | 4.36 | 3.29 |
Current Ratio
10.97
Quick Ratio
10.97
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 10.97 |
| 2026-03-31 | 9.52 |
| 2025-12-31 | 13.78 |
| 2025-09-30 | 8.58 |
| 2025-06-30 | 9.87 |
| 2025-03-31 | 7.75 |
| 2024-12-31 | 12.60 |
| 2024-09-30 | 24.24 |
| 2024-06-30 | 41.70 |
| 2024-03-31 | 21.65 |
| 2023-12-31 | 5.76 |
| 2023-09-30 | 2.89 |
| 2023-06-30 | 2.61 |
| 2023-03-31 | 4.09 |
| 2022-12-31 | 6.89 |
| 2022-09-30 | 7.84 |
| 2022-06-30 | 7.52 |
| 2022-03-31 | 7.38 |
| 2021-12-31 | 11.40 |
| 2021-09-30 | 13.92 |
| 2021-06-30 | 9.93 |
| 2021-03-31 | 13.57 |
| 2020-12-31 | 8.61 |
| 2020-10-31 | 5.11 |
| 2020-06-30 | 3.92 |
| 2019-12-31 | 0.00 |
| 2019-07-31 | 0.00 |
| 2019-04-30 | 0.00 |
| 2019-01-31 | 43.70 |
| 2018-10-31 | 0.00 |
| 2018-07-31 | 27.38 |
| 2018-04-30 | 0.00 |
| 2018-01-31 | 371.70 |
| 2017-10-31 | 16.78 |
